Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research

Contract Research

BMS, PsiOxus Therapeutics to study immuno-oncology combination By PBR Staff Writer
Bristol-Myers Squibb (BMS) and UK-based PsiOxus Therapeutics have agreed to work together on a new combination therapy targeting various tumor types in late-stage cancer patients.
Contract Research & Services > Contract Research > News
TB Alliance, Takeda partner to investigate novel compounds for tuberculosis treatment The Global Alliance for TB Drug Development (TB Alliance) and Takeda Pharmaceutical Company have entered into an agreement that further explores hits generated from a high-throughput screening program conducted to find novel compounds to improve treatment of tuberculosis (TB).
Contract Research & Services > Contract Research > News Genentech, Epizyme to assess anti-cancer effects of tazemetostat/Tecentriq combination By PBR Staff Writer
Roche's subsidiary Genentech and biopharmaceutical firm Epizyme will collaborate on a phase 1b clinical trial to evaluate the combination of tazemetostat and Tecentriq for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL).
Contract Research & Services > Contract Research > News
See more Contract Research news

Latest Contract Research News and Insight

View all Contract Research news or find news targeted to your interests
Genentech, Epizyme to assess anti-cancer effects of tazemetostat/Tecentriq combination
By PBR Staff Writer
Roche's subsidiary Genentech and biopharmaceutical firm Epizyme will collaborate on a phase 1b clinical trial to evaluate the combination of tazemetostat and Tecentriq for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL).
Contract Research & Services > Contract Research > News
ORIG3N, Kangstem Biotech collaborate to study neural stem cells
ORIG3N and Kangstem Biotech have started a scientific collaboration to study the utility of induced neural stem cells (iNSC) in disease modeling.
Contract Research & Services > Contract Research > News
Arkin Holdings, Phoenix Group sign collaboration deal to invest $60m in pharma and biotech companies
Phoenix Group and Arkin Holdings have signed a Strategic Collaboration Agreement for investment in pharma and biotech companies, for a total of approximately $60 Million (with an option to increase the investment in the future).
Contract Research & Services > Contract Research > News
Cantabio, University of Antioquia partner to research therapeutic candidates targeting DJ-1 protein to treat Parkinson’s disease
Cantabio Pharmaceuticals announced its collaboration with the Neuroscience Research Group at the University of Antioquia in Colombia, to further evaluate the company’s DJ-1 protein-targeting small molecule pharmaceutical chaperone drug candidates in development for the treatment of Parkinson’s disease (PD).
Contract Research & Services > Contract Research > News
American Diabetes Association and IBM partner on diabetes management
The American Diabetes Association and IBM Watson Health announced a long-term collaboration to bring together the cognitive computing power of Watson and the Association’s vast repository of clinical and research data.
Contract Research & Services > Contract Research > News
Shire completes decentralized procedure in Europe for immunoglobulin treatment Cuvitru
Shire has completed a decentralized procedure (DCP) to support approval by 17 authorities in Europe for Cuvitru (IG 20mg/ml solution for subcutaneous injection), a treatment for pediatric and adult patients with primary and certain secondary immunodeficiency disorders, a group of disorders in which part of the body's immune system is missing or does not function properly.
Contract Research & Services > Contract Research > News
ReNeuron to tackle brain cancer with exosome platform
By PBR Staff Writer
UK clinical-stage cell therapy development firm ReNeuron Group has selected glioblastoma multiforme (GBM), the most common form of brain cancer, as the initial clinical target for its exosome nanomedicine platform.
Contract Research & Services > Contract Research > News
Bristol-Myers Squibb, MD Anderson form research collaboration in immuno-oncology focused on lung cancer
Bristol-Myers Squibb and The University of Texas MD Anderson Cancer Center today announced a new clinical research collaboration to evaluate innovative strategies for the potential use of Bristol-Myers Squibb’s immuno-oncology (I-O) agents Opdivo (nivolumab) and Yervoy (ipilimumab) to treat early- and advanced-stage lung cancer patients.
Contract Research & Services > Contract Research > News
Kite Pharma, Cell Design Labs collaborate on new CAR T-Cell immunotherapies
By PBR Staff Writer
Kite Pharma and Cell Design Labs have announced a research collaboration and license agreement to develop new CAR T-Cell immunotherapies.
Contract Research & Services > Contract Research > News
Sanofi Genzyme forms multiple sclerosis research collaboration with Johns Hopkins School of Medicine
Sanofi Genzyme, the specialty care global business unit of Sanofi, announced a research collaboration with the Johns Hopkins School of Medicine that will focus on novel strategies aimed at advancing the understanding of underlying causes of disease progression in multiple sclerosis (MS).
Contract Research & Services > Contract Research > News
View all Contract Research news or find news targeted to your interests